Search Results
Results found for "Montana Molecular"
- 📰 GPCR Weekly News, June 3 to June 9, 2024
adenosine receptor signaling and regulation Novel medications for problematic alcohol use Structural and Molecular
- Deficiency of β-arrestin2 alleviates apoptosis through GRP78-ATF6-CHOP signaling pathway in ...
In this study, we established an experimental Sjögren's syndrome (ESS) mouse model to elucidate the molecular
- Why Kinetics Matter More Than Kd in GPCR Drug Discovery
Career opportunities: Principal Scientist - In Vitro Pharmacology; Senior Scientist, Molecular Pharmacology
- Discovery On Target, October 17-20, 2022, Boston, USA
strategies for the discovery and development of novel therapeutic agents ranging from biologics to small molecules
- 📰 GPCR Weekly News, May 20 to 26, 2024
receptor dimer: Classification, future prospects, and pathophysiological perspectives Structural and Molecular
- Extracellular signal-regulated kinases – a potential pathway for GPCR-targeted drug discovery
International Journal of Molecular Sciences, 20(15). Sugiura, R., Satoh, R., & Takasaki, T. (2021).
- 📰 GPCR Weekly News, February 6 to 12, 2023
(June 4 - 8, 2023). 2023 Molecular Pharmacology (GRS) Seminar GRC. (June 10 - 11, 2023).
- The mouse cytomegalovirus G protein-coupled receptor homolog, M33, coordinates key features of ...
IMPORTANCE G protein-coupled receptors (GPCRs) act as cell surface molecular "switches" which regulate
- Ono Enters into Collaboration Agreement with Domain Therapeutics and Université de Montréal for ...
Pascal Neuville; “Domain”) and Université de Montréal (Québec, Canada; “UdM”), to discover novel small molecules
- Mapping Motion: Intermediate States, Deorphanization & Discovery
Triple Labeling Resolves a GPCR Intermediate State by Using Three-Color Single Molecule FRET .
- SYnAbs is now officially accredited as a Research Tax Credit by the French Ministry of Higher...
all our French partners who trust us in the generation of their monoclonal antibodies against small molecules
- InterAx Biotech AG and Boehringer Ingelheim take collaborate to unlock orphan targets leveraging ...
Collaborative efforts aim to accelerate and improve the prediction of first-in-class small molecule agonists
- 📰 GPCR Weekly News, April 15 to 21, 2024
GPCR Symposia Join us on June 7th for our symposium on Structural and Molecular Insights into GPCR Function
- Optimizing HTRF Assays with Fluorescent Ligands: Time-Resolved Fluorescence in GPCR Research
Molecules. 2023 Dec 15;28(24):8107. Molecules. 2023 Dec 15;28(24):8107. doi: 10.3390/molecules28248107 Nørskov-Lauritsen L, Thomsen AR,
- Targeting GPCRs in the CNS: Advances in Drug Discovery Strategies
Most of them are small molecules capable of going through the BBB , and since their targets are on the Molecules. 2023 Dec 15;28(24):8107. doi: 10.3390/molecules28248107
- G protein-coupled receptor signaling: transducers and effectors
continued study of their function and mechanism of action, there is a greater understanding of how effector molecules
- Rescue of Cell Surface Expression and Signaling of Mutant Follicle-Stimulating Hormone Receptors
Pharmacological chaperones are cell-permeant small molecules that engage nascent mutant GPCRs in the mutant follicle-stimulating hormone receptors (FSHRs) with poor cell surface expression using a small-molecule
- Transmembrane domains of GPCR dimers – a novel hot spot for drug discovery
GPCR dimers are very attractive molecular entities since they have been found to drive biased signalling
- 📰 GPCR Weekly News, May 13 to 19, 2024
Adhesion GPCR with Multiple Roles in Human Diseases, Current Status and Future Perspective Structural and Molecular
- Job Opportunity Spotlight #1: Principal Scientist, In Vitro Pharmacology
former colleagues and their description of the company was very intriguing: a biology focused, small molecule
- Beyond Clearance: The Strategic Power of Irreversible Drug Binding
Good molecules can fail quietly at this stage —not because they’re weak, but because they’re too strong If you’re not designing with persistent enzyme interactions in mind, you’re building risk into your molecule
- Chemical signaling regulates axon regeneration via the GPCR-Gqα pathway in Caenorhabditis elegans
Therefore, the ascaroside signaling system provides a unique example of a signaling molecule that regulates C. elegans secretes a family of small-molecule pheromones called ascarosides, which serve various functions
- Activation of the human chemokine receptor CX3CR1 regulated by cholesterol
class A GPCR-Gi complex structures is observed in CX3CR1, which may correlate with three cholesterol molecules
- Inversago Pharma Announces Dosing of First Participant with Metabolic Syndrome in Phase 1B ...
This 28-day trial will test the pharmacokinetics and safety profile of Inversago’s lead molecule, INV
- GPR108 is required for gambogic acid inhibiting NF-κB signaling in cancer
Overall, our findings supported GPR108 as a promising therapeutic target of cancer, and provided a small molecule
- The regulation of PKA signaling in obesity and in the maintenance of metabolic health
PKA facilitates the actions of hormones, neurotransmitters and other signaling molecules that bind G-protein
- Allosteric modulation of GPCRs: From structural insights to in silico drug discovery
, we provide a systematic analysis of the currently available GPCR structures in complex with small-molecule
- Orion Announces The Rapid Lead Optimization Of Ob-004 - A Ccr2 Antagonist
Protein-Coupled Receptors (GPCRs) with a novel drug modality, proven discovery platform and best-in-class molecules
- Terry’s Corner, Celtarys' Leap, and the $7B GPCR Horizon
Keep pushing the boundaries, because your work moves molecules and medicine forward.
- Finding needles in haystacks: Omass unveils pipeline aimed at tough-to-drug targets
structure-based technology has passed a key test, in enabling the discovery of orally available small molecules









